Eupraxia Pharmaceuticals Inc. Common Stock Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.17 | -$0.17 | -$0.17 |
| Q2 2024 | 1 | -$0.13 | -$0.13 | -$0.13 |
| Q3 2024 | 1 | -$0.14 | -$0.14 | -$0.14 |
| Q1 2025 | 1 | -$0.14 | -$0.14 | -$0.14 |
| Q2 2025 | 1 | -$0.15 | -$0.15 | -$0.15 |
| Q3 2025 | 1 | -$0.16 | -$0.16 | -$0.16 |
| Q4 2025 | 1 | -$0.14 | -$0.14 | -$0.14 |
Eupraxia Pharmaceuticals Inc. Common Stock Earnings Date And Information
Eupraxia Pharmaceuticals Inc. Common Stock last posted its earnings results on N/A. The company reported $N/A earnings per share for the quarter, missing analysts' consensus estimates of $N/A by $0. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Eupraxia Pharmaceuticals Inc. Common Stock has generated $-2 earnings per share over the last year ($-1.55 diluted earnings per share) and currently has a price-to-earnings ratio of -5.04. Eupraxia Pharmaceuticals Inc. Common Stock has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, April 1st, 2025 based on prior year's report dates.
Eupraxia Pharmaceuticals Inc. Common Stock Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 09/30/2024 | Q3 2024 | -$0.17 | $0 | $0 | ||
| 06/29/2024 | Q2 2024 | -$0.17 | $0 | $0 | ||
| 03/30/2024 | Q1 2024 | -$0.21 | $0 | |||
| 12/30/2023 | Q4 2023 | -$0.15 | $2.98 M | |||
| 09/29/2023 | Q3 2023 | -$0.18 | $0 | |||
| 06/29/2023 | Q2 2023 | -$0.27 | $0 | |||
| 03/30/2023 | Q1 2023 | -$0.17 | $0 | |||
| 12/29/2022 | Q4 2022 | -$0.51 | $1.92 M | |||
| 09/29/2022 | Q3 2022 | -$0.25 | $0 | |||
| 06/28/2022 | Q2 2022 | -$0.24 | $0 | |||
| 03/29/2022 | Q1 2022 | -$0.21 | $0 | |||
| 12/29/2021 | Q4 2021 | -$0.21 | $0 | |||
| 09/28/2021 | Q3 2021 | -$0.28 | $0 | |||
| 06/28/2021 | Q2 2021 | -$0.33 | $0 |
Eupraxia Pharmaceuticals Inc. Common Stock Earnings: Frequently Asked Questions
-
When is Eupraxia Pharmaceuticals Inc. Common Stock's earnings date?
Eupraxia Pharmaceuticals Inc. Common Stock has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, April 1st, 2025 based off last year's report dates.
-
How can I listen to Eupraxia Pharmaceuticals Inc. Common Stock's earnings conference call?
The conference call for Eupraxia Pharmaceuticals Inc. Common Stock's latest earnings report can be listened to online.
-
How can I read Eupraxia Pharmaceuticals Inc. Common Stock's conference call transcript?
The conference call transcript for Eupraxia Pharmaceuticals Inc. Common Stock's latest earnings report can be read online.
-
How much profit does Eupraxia Pharmaceuticals Inc. Common Stock generate each year?
Eupraxia Pharmaceuticals Inc. Common Stock (:EPRX) has a recorded net income of $0. Eupraxia Pharmaceuticals Inc. Common Stock has generated $-1.55 earnings per share over the last four quarters.
-
What is Eupraxia Pharmaceuticals Inc. Common Stock's price-to-earnings ratio?
Eupraxia Pharmaceuticals Inc. Common Stock (:EPRX) has a price-to-earnings ratio of -5.04 and price/earnings-to-growth ratio is -3.58.
